Cargando…
Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: Pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells
Promoter hypermethylation of tumor suppressor genes (TSGs) is a common feature of primary cancer cells. However, to date the somatic epigenetic events that occur in head and neck squamous cell carcinoma (HNSCC) tumorigenesis have not been well-defined. In the present study, we analyzed the promoter...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583513/ https://www.ncbi.nlm.nih.gov/pubmed/22246327 http://dx.doi.org/10.3892/or.2012.1624 |
_version_ | 1782475434923917312 |
---|---|
author | KOUTSIMPELAS, DIMITRIOS PONGSAPICH, WARUT HEINRICH, ULF MANN, SYLVIA MANN, WOLF J. BRIEGER, JÜRGEN |
author_facet | KOUTSIMPELAS, DIMITRIOS PONGSAPICH, WARUT HEINRICH, ULF MANN, SYLVIA MANN, WOLF J. BRIEGER, JÜRGEN |
author_sort | KOUTSIMPELAS, DIMITRIOS |
collection | PubMed |
description | Promoter hypermethylation of tumor suppressor genes (TSGs) is a common feature of primary cancer cells. However, to date the somatic epigenetic events that occur in head and neck squamous cell carcinoma (HNSCC) tumorigenesis have not been well-defined. In the present study, we analyzed the promoter methylation status of the genes mutL homolog 1 (MLH1), Ras-association domain family member 1 (RASSF1A) and O-6-methylguanine-DNA methyltransferase (MGMT) in 23 HNSCC samples, three control tissues and one HNSCC cell line (UM-SCC 33) using methylation-specific PCR (MSP). The expression of the three proteins was quantified by semi-quantitative immunohistochemical analysis. The cell line was treated with the demethylating agent 5-azacytidine (5-Aza) and the methylation status after 5-Aza treatment was analyzed by MSP and DNA sequencing. Proliferation was determined by Alamar blue staining. We found that the MGMT promoter in 57% of the analyzed primary tumor samples and in the cell line was hypermethylated. The MLH promoter was found to be methylated in one out of 23 (4%) tumor samples while in the examined cell line the MLH promoter was unmethylated. The RASSF1A promoter showed methylation in 13% of the tumor samples and in the cell line. MGMT expression in the group of tumor samples with a hypermethylated promoter was statistically significantly lower compared to the group of tumors with no measured hypermethylation of the MGMT promoter. After treatment of the cell line with the demethylating agent 5-Aza no demethylation of the methylated MGMT and RASSF1A genes were determined by MSP. DNA sequencing verified the MSP results, however, increased numbers of unmethylated CpG islands in the promoter region of MGMT and RASSF1A were observed. Proliferation was significantly (p<0.05) reduced after treatment with 5-Aza. In summary, we have shown promoter hypermethylation of the tumor suppressor genes MGMT and RASSF1A in HNSCC, suggesting that this epigenetic inactivation of TSGs may play a role in the development of HNSCC. 5-Aza application resulted in partial demethylation of the MGMT and RASSF1A TSGs and reduced proliferation of the tumor cells suggesting further evaluation of 5-Aza for HNSCC treatment. |
format | Online Article Text |
id | pubmed-3583513 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-35835132013-02-28 Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: Pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells KOUTSIMPELAS, DIMITRIOS PONGSAPICH, WARUT HEINRICH, ULF MANN, SYLVIA MANN, WOLF J. BRIEGER, JÜRGEN Oncol Rep Articles Promoter hypermethylation of tumor suppressor genes (TSGs) is a common feature of primary cancer cells. However, to date the somatic epigenetic events that occur in head and neck squamous cell carcinoma (HNSCC) tumorigenesis have not been well-defined. In the present study, we analyzed the promoter methylation status of the genes mutL homolog 1 (MLH1), Ras-association domain family member 1 (RASSF1A) and O-6-methylguanine-DNA methyltransferase (MGMT) in 23 HNSCC samples, three control tissues and one HNSCC cell line (UM-SCC 33) using methylation-specific PCR (MSP). The expression of the three proteins was quantified by semi-quantitative immunohistochemical analysis. The cell line was treated with the demethylating agent 5-azacytidine (5-Aza) and the methylation status after 5-Aza treatment was analyzed by MSP and DNA sequencing. Proliferation was determined by Alamar blue staining. We found that the MGMT promoter in 57% of the analyzed primary tumor samples and in the cell line was hypermethylated. The MLH promoter was found to be methylated in one out of 23 (4%) tumor samples while in the examined cell line the MLH promoter was unmethylated. The RASSF1A promoter showed methylation in 13% of the tumor samples and in the cell line. MGMT expression in the group of tumor samples with a hypermethylated promoter was statistically significantly lower compared to the group of tumors with no measured hypermethylation of the MGMT promoter. After treatment of the cell line with the demethylating agent 5-Aza no demethylation of the methylated MGMT and RASSF1A genes were determined by MSP. DNA sequencing verified the MSP results, however, increased numbers of unmethylated CpG islands in the promoter region of MGMT and RASSF1A were observed. Proliferation was significantly (p<0.05) reduced after treatment with 5-Aza. In summary, we have shown promoter hypermethylation of the tumor suppressor genes MGMT and RASSF1A in HNSCC, suggesting that this epigenetic inactivation of TSGs may play a role in the development of HNSCC. 5-Aza application resulted in partial demethylation of the MGMT and RASSF1A TSGs and reduced proliferation of the tumor cells suggesting further evaluation of 5-Aza for HNSCC treatment. D.A. Spandidos 2012-01-09 2012-04 /pmc/articles/PMC3583513/ /pubmed/22246327 http://dx.doi.org/10.3892/or.2012.1624 Text en Copyright © 2012, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Articles KOUTSIMPELAS, DIMITRIOS PONGSAPICH, WARUT HEINRICH, ULF MANN, SYLVIA MANN, WOLF J. BRIEGER, JÜRGEN Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: Pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells |
title | Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: Pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells |
title_full | Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: Pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells |
title_fullStr | Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: Pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells |
title_full_unstemmed | Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: Pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells |
title_short | Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: Pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells |
title_sort | promoter methylation of mgmt, mlh1 and rassf1a tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583513/ https://www.ncbi.nlm.nih.gov/pubmed/22246327 http://dx.doi.org/10.3892/or.2012.1624 |
work_keys_str_mv | AT koutsimpelasdimitrios promotermethylationofmgmtmlh1andrassf1atumorsuppressorgenesinheadandnecksquamouscellcarcinomapharmacologicalgenomedemethylationreducesproliferationofheadandnecksquamouscarcinomacells AT pongsapichwarut promotermethylationofmgmtmlh1andrassf1atumorsuppressorgenesinheadandnecksquamouscellcarcinomapharmacologicalgenomedemethylationreducesproliferationofheadandnecksquamouscarcinomacells AT heinrichulf promotermethylationofmgmtmlh1andrassf1atumorsuppressorgenesinheadandnecksquamouscellcarcinomapharmacologicalgenomedemethylationreducesproliferationofheadandnecksquamouscarcinomacells AT mannsylvia promotermethylationofmgmtmlh1andrassf1atumorsuppressorgenesinheadandnecksquamouscellcarcinomapharmacologicalgenomedemethylationreducesproliferationofheadandnecksquamouscarcinomacells AT mannwolfj promotermethylationofmgmtmlh1andrassf1atumorsuppressorgenesinheadandnecksquamouscellcarcinomapharmacologicalgenomedemethylationreducesproliferationofheadandnecksquamouscarcinomacells AT briegerjurgen promotermethylationofmgmtmlh1andrassf1atumorsuppressorgenesinheadandnecksquamouscellcarcinomapharmacologicalgenomedemethylationreducesproliferationofheadandnecksquamouscarcinomacells |